AA&MDSIF
@aamdsif
Aplastic Anemia and MDS Int'l Found supports patients & families with #aplastic anemia, #MDS, #PNH, and related bone marrow failure diseases #AML #PRCA #CMML
ICYMI: Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab journals.sagepub.com/doi/10.1177/20…
Brian has been through it all with MDS- first Low Risk, then High Risk and Transplant, and now Survivorship! Listen to him explain how he "kept his chin up" through all of this in this podcast episode: aamds.org/podcast/brian-… #MDS #bloodcancer
New article alert! 🚨🚨 Dr. @Anand_88_Patel and 3rd year @UCHemOncFellows Dr. Yates are published in @Haematologica sharing the results of the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)! haematologica.org/article/view/1…
This last weekend in July, spend some time W @JasmineKambojMD on #HUExpress advising Hem/Onc fellows starting training this month. "How to Survive & Thrive in fellowship?" @HemOncFellows @TheFellowOnCall @IMG_Oncologists @ASCO @Noha_Soror @marklewismd @docbraunstein @VincentRK
Two of our fellows presented at the @OncLive Fellows Forum - highlighting the emerging role of tarlatamab and the changing burden of lung cancer in AYA population! Promoting research and presentation opportunities is a vital part of academic oncology training @SylvesterCancer
New podcast with @szusmani & SOHO President @scheinbp out now! The pair talk about #SOHO2025 and the benefits of membership. Join us 😍 soho.click/2025 sohoinsider.com/news/drs-saad-…
Just one week to submit a workshop proposal for #ASPHO2026! Share your expertise and knowledge with the #PedsHemeOnc community in Minneapolis. Submissions will be accepted through July 31 at 3pm CT. aspho.org/meetings/confe…
🎥 Dr Harry Erba @DukeCancer discusses NPM1 mutations in acute myeloid leukemia and current ongoing research into the treatment of NPM1-mutated acute myeloid leukemia. Watch the full video here: loom.ly/DbwlyUs #AMLsm #leusm #MedEd
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia ashpublications.org/blood/article/… 70 cases of B-cell #ALL with lineage switch after immunotherapy (anti-CD19) to AML or mixed phenotypic leukemia. Dismal outcome with…
Growing up, I thought I’d be working in the music industry. Music was my first love. Ending up in transplant and cell therapy was the last thing I would have expected, but I have no regrets. This job is amazing. ❤️ trafficeast.com/inside-the-arc…
ICYMI: Detecting and quantifying clonal selection in somatic stem cells nature.com/articles/s4158…
“Look for the light in every day” Here is Lisa's final release day, after the second transplant! Lisa has moved forward to encourage others through their Bone Marrow Failure disease. Read her story here: aamds.org/patient-chroni… #transplant #bonemarrowfailure
ICYMI: Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency nature.com/articles/s4140…
Caregivers or Family Members: It's time to plan your respite. Taking care of You is as important as taking care of your loved one. Find resources aamds.org/support/extern… (General Support Resources) or call your local 211 assistance number to find respite help in your community.
Fantastic presentation from @samsekeres today for the @SylvesterCancer SURF program poster day! Excited about this project and the progress she made this summer!
Another #ProudPapa moment as @samsekeres presents her data on BTK degrader resistance in #CLL from the @TaylorJ_MD lab sponsored by @theNCI summer undergrad research fellowship! @SylvesterCancer @UMiamiHealth @univmiami
@TaylorJ_MD you are an extraordinary mentor!!!
Fantastic presentation from @samsekeres today for the @SylvesterCancer SURF program poster day! Excited about this project and the progress she made this summer!
ICYMI: Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab journals.sagepub.com/doi/10.1177/20…
ICYMI: Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation ascopubs.org/doi/full/10.12…
Having Aplastic Anemia, MDS, or PNH is hard! What do you need to do to ease symptoms as you are living with bone marrow failure and its treatment? Find out by watching this recording from the 2025 Kansas City Patient and Family Conference: aamds.org/webinar/living…
ICYMI: The role of ASXL1, SRSF2, and EZH2 mutations in chromatin dysregulation of myelodysplastic neoplasia and acute myeloid leukemia nature.com/articles/s4137…
